A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.
The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.
The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.
It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).
.@DoHSocial has partnered with Swiss healthcare company @Roche to provide a new Covid-19 medication, approved for emergency use, to treat mild to moderate Covid-19 cases and those who have had direct contact with a positive case.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) December 1, 2021
Read more: https://t.co/vGQXyUvhGB pic.twitter.com/Yj9JxVgemP
Dubai Police reunites missing 6-year-old with family in 30 minutes
UAE's Shakhboot bin Nahyan holds talks with Lesotho's Minister of Foreign Affairs
UAE steps up relief efforts for flood, landslide victims in Nepal
UAE, Turkey Presidents review regional developments
Dubai Police reintegration programme delivers sharp drop in youth misconduct
UAE President pardons Abdul Rahman Yusuf Al-Qaradawi
UAE President congratulates Italian PM on longest-serving government
UAE relief mission departs for flood-hit Nepal
